Pfizer starts investigation of oral drug for counteraction of COVID-19 Kumar Jeetendra | September 27, 2021 Pfizer Inc said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus. The company and its rivals, including U.S.-based Merck & Co Inc and Swiss pharmaceutical Roche Holding AG, have been racing to develop the …
Pfizer ranked as leading company in Asia for covid-19 response and patient-centric approach by Asian patient groups Kumar Jeetendra | August 26, 2022 SINGAPORE, 26 AUGUST 2022 — Pfizer had been ranked first in its Covid-19 response, patient centricity, patient safety and bringing innovative, high-quality products amongst pharma companies in Asia in the ‘Corporate Reputation of Pharma’ survey by patient groups across the APAC region. Overall, the company is ranked second for its corporate reputation across Asian countries. …
